Dabucon, Nereka M.
HRN: 25-35-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
CEFIXIME 200MG (CAP)
07/04/2024
07/11/2024
PO
400mg
BID
CKD; CAP-MR
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes